VOYA Investment Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,488
| Closed | -$467K | – | 2690 |
|
|
2024
Q4 | $467K | Sell |
29,488
-145,806
| -83% | -$2.31M | ﹤0.01% | 1965 |
|
|
2024
Q3 | $10.2M | Buy |
175,294
+119,197
| +212% | +$6.92M | 0.01% | 759 |
|
|
2024
Q2 | $2.56M | Sell |
56,097
-3,176
| -5% | -$145K | ﹤0.01% | 1240 |
|
|
2024
Q1 | $3.92M | Buy |
59,273
+25,638
| +76% | +$1.7M | ﹤0.01% | 1096 |
|
|
2023
Q4 | $1.34M | Sell |
33,635
-38,511
| -53% | -$1.53M | ﹤0.01% | 1523 |
|
|
2023
Q3 | $2.3M | Buy |
72,146
+154
| +0.2% | +$4.91K | ﹤0.01% | 1277 |
|
|
2023
Q2 | $2.89M | Buy |
71,992
+1,808
| +3% | +$72.6K | ﹤0.01% | 1210 |
|
|
2023
Q1 | $3M | Hold |
70,184
| – | – | ﹤0.01% | 1185 |
|
|
2022
Q4 | $3.37M | Sell |
70,184
-17,226
| -20% | -$827K | ﹤0.01% | 1121 |
|
|
2022
Q3 | $3.29M | Buy |
+87,410
| New | +$3.29M | ﹤0.01% | 1129 |
|
|
2022
Q2 | – | Sell |
-6,131
| Closed | -$333K | – | 2837 |
|
|
2022
Q1 | $333K | Hold |
6,131
| – | – | ﹤0.01% | 2126 |
|
|
2021
Q4 | $359K | Buy |
6,131
+25
| +0.4% | +$1.46K | ﹤0.01% | 2200 |
|
|
2021
Q3 | $242K | Hold |
6,106
| – | – | ﹤0.01% | 2467 |
|
|
2021
Q2 | $259K | Buy |
6,106
+122
| +2% | +$5.18K | ﹤0.01% | 2455 |
|
|
2021
Q1 | $368K | Buy |
5,984
+504
| +9% | +$31K | ﹤0.01% | 2194 |
|
|
2020
Q4 | $387K | Buy |
+5,480
| New | +$387K | ﹤0.01% | 2063 |
|